CN118325843A - Low-protein serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production and application thereof - Google Patents
Low-protein serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production and application thereof Download PDFInfo
- Publication number
- CN118325843A CN118325843A CN202310041867.0A CN202310041867A CN118325843A CN 118325843 A CN118325843 A CN 118325843A CN 202310041867 A CN202310041867 A CN 202310041867A CN 118325843 A CN118325843 A CN 118325843A
- Authority
- CN
- China
- Prior art keywords
- serum
- free medium
- mug
- acid
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004408 hybridoma Anatomy 0.000 title claims abstract description 35
- 238000004114 suspension culture Methods 0.000 title claims abstract description 18
- 230000016784 immunoglobulin production Effects 0.000 title claims abstract description 13
- 239000004017 serum-free culture medium Substances 0.000 title abstract description 21
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000001963 growth medium Substances 0.000 claims abstract description 15
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 10
- 102000004877 Insulin Human genes 0.000 claims abstract description 10
- 102000004338 Transferrin Human genes 0.000 claims abstract description 10
- 229940098773 bovine serum albumin Drugs 0.000 claims abstract description 10
- 229940125396 insulin Drugs 0.000 claims abstract description 10
- 239000012581 transferrin Substances 0.000 claims abstract description 10
- 235000004252 protein component Nutrition 0.000 claims abstract description 8
- 108090001061 Insulin Proteins 0.000 claims abstract description 7
- 235000001014 amino acid Nutrition 0.000 claims abstract description 7
- 150000001413 amino acids Chemical class 0.000 claims abstract description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 5
- 150000002632 lipids Chemical class 0.000 claims abstract description 5
- 239000003223 protective agent Substances 0.000 claims abstract description 5
- 239000011573 trace mineral Substances 0.000 claims abstract description 5
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 5
- 101000766308 Bos taurus Serotransferrin Proteins 0.000 claims abstract description 4
- 239000007853 buffer solution Substances 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 229940088594 vitamin Drugs 0.000 claims abstract description 3
- 229930003231 vitamin Natural products 0.000 claims abstract description 3
- 235000013343 vitamin Nutrition 0.000 claims abstract description 3
- 239000011782 vitamin Substances 0.000 claims abstract description 3
- 239000012679 serum free medium Substances 0.000 claims description 24
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 12
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 10
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 8
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 6
- 108090000901 Transferrin Proteins 0.000 claims description 6
- 229940024606 amino acid Drugs 0.000 claims description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 5
- 235000019743 Choline chloride Nutrition 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 5
- 239000005642 Oleic acid Substances 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 5
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 5
- 229960003178 choline chloride Drugs 0.000 claims description 5
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 5
- 229960000367 inositol Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 5
- FCHXJFJNDJXENQ-UHFFFAOYSA-N pyridoxal hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(C=O)=C1O FCHXJFJNDJXENQ-UHFFFAOYSA-N 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 235000019192 riboflavin Nutrition 0.000 claims description 5
- 239000002151 riboflavin Substances 0.000 claims description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 4
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 235000009697 arginine Nutrition 0.000 claims description 4
- 235000009582 asparagine Nutrition 0.000 claims description 4
- 229960001230 asparagine Drugs 0.000 claims description 4
- 239000007640 basal medium Substances 0.000 claims description 4
- 229960002079 calcium pantothenate Drugs 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- 101001011741 Bos taurus Insulin Proteins 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
- 235000004279 alanine Nutrition 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 229960003067 cystine Drugs 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical group C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 229920001993 poloxamer 188 Polymers 0.000 claims description 2
- 235000019157 thiamine Nutrition 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- 239000011721 thiamine Substances 0.000 claims description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims 1
- 235000021319 Palmitoleic acid Nutrition 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 229940114079 arachidonic acid Drugs 0.000 claims 1
- 235000021342 arachidonic acid Nutrition 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical group [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 229960001471 sodium selenite Drugs 0.000 claims 1
- 235000015921 sodium selenite Nutrition 0.000 claims 1
- 239000011781 sodium selenite Substances 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 238000004113 cell culture Methods 0.000 abstract description 9
- 210000002966 serum Anatomy 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 235000018102 proteins Nutrition 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 5
- 239000000243 solution Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 40
- 239000000047 product Substances 0.000 description 16
- 230000012010 growth Effects 0.000 description 12
- 230000010261 cell growth Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- -1 antibodies Substances 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 229960004642 ferric ammonium citrate Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229940083563 folic acid 1 mg Drugs 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 235000000011 iron ammonium citrate Nutrition 0.000 description 2
- 239000004313 iron ammonium citrate Substances 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 229940088174 thiamine 1 mg Drugs 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- YEBDWAHEIMUJQT-ZLCLUPBPSA-N (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O.CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YEBDWAHEIMUJQT-ZLCLUPBPSA-N 0.000 description 1
- YZAZXIUFBCPZGB-QZOPMXJLSA-N (z)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O YZAZXIUFBCPZGB-QZOPMXJLSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 101100346155 Caenorhabditis elegans oma-2 gene Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HANWNMVUNKQMDJ-UHFFFAOYSA-L [Na+].[Na+].O[Se](O)=O.[O-][Se]([O-])=O Chemical compound [Na+].[Na+].O[Se](O)=O.[O-][Se]([O-])=O HANWNMVUNKQMDJ-UHFFFAOYSA-L 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- GICLSALZHXCILJ-UHFFFAOYSA-N ctk5a5089 Chemical compound NCC(O)=O.NCC(O)=O GICLSALZHXCILJ-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- XMFASNZWWPHTPG-UULNMNGPSA-N hexadecanoic acid;(z)-hexadec-9-enoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCC\C=C/CCCCCCCC(O)=O XMFASNZWWPHTPG-UULNMNGPSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 229940087417 methionine 150 mg Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 229940000207 selenious acid Drugs 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-N selenous acid Chemical compound O[Se](O)=O MCAHWIHFGHIESP-UHFFFAOYSA-N 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- WYPBVHPKMJYUEO-NBTZWHCOSA-M sodium;(9z,12z)-octadeca-9,12-dienoate Chemical compound [Na+].CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O WYPBVHPKMJYUEO-NBTZWHCOSA-M 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a low-protein serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production and application thereof. The culture medium is based on DMEM/F12 (v/v, 1:1), and bovine serum albumin, transferrin and 3 protein components of insulin, 19 amino acids, 8 vitamins, 8 lipids, trace elements, a protective agent, a buffer solution and other non-protein substances are added. The culture medium has the characteristics of low protein content and basically definite chemical composition, not only can meet the requirement of hybridoma cell suspension culture, but also can effectively avoid the problem that the product purification is not facilitated due to the use of serum; the culture medium also has the characteristic of strong universality, can obviously reduce the cost of cell culture solution, and is suitable for the mass production and industrial application of hybridoma cells.
Description
Technical Field
The invention relates to a cell culture and culture medium research and development technology in the field of biotechnology, in particular to a serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production and application thereof.
Background
Cell culture is to realize in vitro cell culture by simulating in vivo cell growth environment, and animal cell in vitro culture technology is widely applied in the fields of research on physiological, biochemical and pharmacological activities of cells and tissues and the industrial production fields of biological products such as antibodies, hormones, vaccines and the like. Wherein the cell culture medium is a vital part of the cell in vitro culture technology. The traditional serum-containing culture medium contains a large amount of components necessary for cell growth proliferation such as various growth factors, plasma proteins, polypeptides, hormones and the like, but the serum has the problems of large batch-to-batch difference, potential pollution risk, undefined components, adverse separation and purification of target products, easy infection by viruses and mycoplasma and the like, and the serum-free culture medium has the advantages of simple preparation process, consistent quality and low protein content due to relatively defined components, is favorable for improving the production stability of cell products and facilitating the purification of the cell products, and can be widely applied to the field of modern biotechnology.
There are also many reports on components of serum component substitutes that promote cell growth. Albumin is a major additive factor for many serum-free media, and has the effects of regulating osmotic pressure, protecting cells from mechanical damage, and the like. Li Ping et al (Li Ping, jiang Lin, huang Saiyang, etc.), study of serum-free culture of chinese hamster ovary engineering cells [ J ] microbiological immunological progress 2004, 32 (4): 46-50) experiments showed that albumin also had a remarkable effect of stabilizing cell growth and increasing the expression level of cell strain products. The serum-free medium for general suspension culture contains bovine serum albumin. Hu Xuemei et al (Hu Xuemei, zhang Yuanxing, amino acids acting on chinese hamster ovary cells in serum-free medium [ J ] university of eastern China university of technology 1996, 22 (6): 283-285) examined the influence of 15 amino acids and their concentrations on cell culture in CHO cell serum-free culture by orthogonal assay, and the results showed that the added arginine, leucine, proline and methionine had a remarkable promoting effect on cell growth, whereas serine and tryptophan at high concentrations had a remarkable inhibiting effect on cell growth. Insulin promotes synthesis of RNA, protein and fatty acid, inhibits apoptosis, and is an important cell survival factor. Jan et al (Jan L,Haggstrorm L.Specific growth rate as a parameter fortracing growth-limiting substances in animal cell cultures〔J〕.Journal of Biotechnology 1995,42:163~165) believe that rapid depletion of insulin in batch culture is the primary cause of a decrease in the specific growth rate of cells. Selenium has obvious effect in the growth process of mammalian cells, and trace element selenium participates in the action process of glutathione peroxidase and superoxide dismutase to eliminate the damage of oxidase and oxygen free radical to cells. Xue Qingshan (Xue Qingshan, in vitro culture principles and techniques [ M ] Beijing science and technology Press, 2001, 162-164) states that the addition of selenious acid in an appropriate amount can promote cell growth, but if the concentration is too high, it can exert toxic effects on cells.
The commercial serum-free culture medium is mainly imported, the price is high, and the formula is kept secret, so that the serum-free culture medium which can support the rapid growth of hybridoma cells and the high expression of monoclonal antibodies is independently researched and developed, and related process optimization and amplification are carried out to meet the requirement of expressing the monoclonal antibodies in a large quantity.
Disclosure of Invention
The invention aims to provide a low-protein serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production so as to meet the requirements of hybridoma cell suspension culture and monoclonal antibody production. The hybridoma cell is an infinite passage cell capable of secreting a single unique antibody, and the secreted monoclonal antibody has wide application in vaccine production, in-vitro diagnosis and biological medicine. The culture medium can enable the hybridoma cells to grow normally under the suspension condition and express the monoclonal antibody.
To achieve the above object, the present invention provides a serum-free medium suitable for hybridoma cell suspension culture and monoclonal antibody production, the serum-free medium comprising a basal medium and an additive factor, wherein:
The basic culture medium is DMEM and F12, and the volume ratio is 1:1;
the additive factors comprise protein components, amino acids, microorganisms, lipids, trace elements, protective agents and buffer solutions;
The protein component is bovine serum albumin, transferrin and insulin.
Wherein the dosage of the protein components is respectively as follows: bovine serum albumin (Bovine serum albumin) 10.0-20.0mg/L, transferrin (Transferrin) 2.5-15.5mg/L, insulin (Transferrin) 5.0-15.0mg/L.
The components and the amounts of the amino acid are as follows: arginine (L-Arginine) 20-60mg/L, cystine (L-Cystine) 5-15mg/L, histidine (L-HISTIDINE) 5-20mg/L, isoleucine (L-Isoleucine) 10-25mg/L, leucine (L-Leucine) 10-25mg/L, lysine (L-Lysine) 10-25mg/L, methionine (L-Methionine) 10-20mg/L, phenylalanine (L-PHENYLALANINE) 10-25mg/L, threonine (L-Threonine) 10-25mg/L, tryptophan (L-Tryptophan) 2-20mg/L, tyrosine (L-Tyrosine) 5-20mg/L, valine (L-Valine) 10-30mg/L, glycine (Glycine) 2-10mg/L, alanine (L-Alanine) 2-10mg/L, asparagine (L-ASPARAGINE) 2-20mg/L, aspartic acid (L-ASPARTICACID) 2-20mg/L, glutamic acid (L-28) 2-20mg/L, proline (L-34) 2-30 mg/L, and Proline (L-34) 2-76 mg/L.
The components and the dosage of the vitamins are as follows: choline chloride (Choline chloride) 0.5-2.0mg/L, calcium pantothenate (D-Calcium pantothenate) 0.5-2.0mg/L, folic acid (Folic acid) 0.5-2.0mg/L, niacinamide (Nicotinamida) 0.5-2.0mg/L, pyridoxal hydrochloride (Pyridoxal hydrochloride) 0.5-2.0mg/L, riboflavin (Riboflavin) 0.5-2.0mg/L, thiamine (Thiamine hydrochloride) 0.5-2.0mg/L, inositol (Inositol) 0.5-2.0mg/L.
The lipid components and the dosage are as follows: 10-50 mug/L of arachidonic acid (Arachidonic acid), 1000-3000 mug/L of Cholesterol (Cholesterol), 30-300 mug/L of Linoleic acid (Linoleic acid), 30-300 mug/L of linolenic acid (Linolenicacid), 30-300 mug/L of oleic acid (Oleic acid), 30-300 mug/L of palmitoleic acid (PALMITIC ACID), 30-300 mug/L of stearic acid (STEARIC ACID), 1000-4000 mug/L of ethanolamine (Ethanolamine).
The microelements are sodium selenite (Selenous acid), and the dosage is 2-20 mug/L.
The buffer solution is sodium bicarbonate (Sodium bicarbonate) and Hepes, the dosage of the sodium bicarbonate is 1-3g/L, and the dosage range of the Hepes is 2-40mg/L.
The shear force resistant protective agent is Pluronic F-68, and the dosage is 500-1000mg/L.
Serum-free medium was prepared by conventional methods.
The invention also provides application of the serum-free culture medium in hybridoma cell suspension culture and monoclonal antibody production.
The invention adopts three protein substances of bovine serum albumin, transferrin and insulin with low content and definite sources to replace substances such as growth factors in the traditional serum culture medium, develops a serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production, can meet the culture requirement of hybridoma cells, effectively avoid a plurality of adverse factors caused by using serum, reduce the production cost and lead the expression quantity of monoclonal antibodies to be equivalent to that of commercial serum-free culture.
The serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production has the positive effects that:
(1) The hybridoma cells can be well supported, and the highest cell density and the antibody yield of the hybridoma cells reach the commercial culture medium effect of the GIBCO brand;
(2) The components are clear, and only three protein components are contained, so that the separation and purification of the product are utilized, and the quality of the product is improved;
(3) The hybridoma cells are supported to be stably subcultured, and can be directly cultured without adaptation;
(4) The components are clear, the preparation is convenient, and the preparation method is suitable for mass production and application;
(5) The use cost of the serum-free culture medium is reduced, and the serum-free culture medium of Gibco brand hybrid-SFM is known through inquiry, and the sales price of the official net is 977 yuan/500 mL; the domestic standard product, the official network shows that the selling price interval is 300-400 yuan/500 mL; the initial accounting cost of the product is less than 250 yuan/500 mL, and the cost can be further reduced after the large-scale preparation is realized.
Drawings
The foregoing and/or other advantages of the invention will become more apparent from the following detailed description of the invention when taken in conjunction with the accompanying drawings and detailed description.
FIG. 1AE-1 cell resuscitates to the cellular State in T75 flask
FIG. 2 shows a graph of growth of hybridoma cell AE-1 strain in serum-free medium of the invention;
FIG. 3 recovery of Hybridoma-2 cells to cellular status in 125mL shake flask
FIG. 4 shows a graph of growth of Hybridoma cell lines in serum-free medium according to the invention and domestic homogeneous serum-free medium.
Detailed Description
Example 1 serum-free medium preparation and cell culture.
(1) Preparation of the culture Medium
In a basal medium based on DMEM/F12 (v/v, 1:1), the following substances were added to the basal medium:
Bovine serum albumin 10.0mg/L, transferrin 6mg/L, insulin 5mg/L, arginine 116mg/L, cystine 22mg/L, histidine 35mg/L, isoleucine 42mg/L, leucine 42mg/L, lysine 65mg/L, methionine 120mg/L, phenylalanine 23mg/L, threonine 40mg/L, tryptophan 8mg/L, tyrosine 26mg/L, valine 40mg/L, glycine 6.5mg/L, alanine 7.9mg/L, asparagine 12.2mg/L, aspartic acid 12.3mg/L, glutamic acid 13.7mg/L, proline 10.5mg/L, serine 8mg/L, glutamine 700mg/L, choline chloride 1mg/L, calcium pantothenate 1mg/L, folic acid 1mg/L, niacinamide 1mg/L, pyridoxal hydrochloride 1mg/L, riboflavin 0.1mg/L, thiamine 1mg/L, inositol 2mg/L, ferric ammonium citrate 8mg/L, sodium chloride 100mg/L, sodium oleate 130 μg/L, sodium linoleate 130 μg/L, sodium bicarbonate 130 μg/L, 50 μg/g of oleic acid, and 130 μg/L of linolenic acid. The medium was prepared according to the conventional method and then sterilized by filtration through a 0.22 μm microporous filter.
(2) Cell culture
The hybridoma cell line AE-1 (purchased from the cell bank of the department of chinese sciences, AE-1 is the cell name in a T75 square bottle, cell density at recovery is 0.59×10 6 cells/mL, the activity is 92% as shown in fig. 1), and then placed in a CO 2 incubator saturated with 5% CO 2 humidity for subculture at 37 ℃.
(3) Comparison with GIBCO brand serum-free Medium Hybridoma-SFM
The cells were subjected to expansion culture to prepare a cell suspension, inoculated into 125 shake flasks at an initial culture density of about 0.2X10 6 cells/ml, and then subjected to suspension culture in a saturated incubator with 5% CO 2 humidity at 37 ℃.
As shown in FIG. 2, the yellow line graph shows the growth curve of the Hybridoma cells cultured in the serum-free medium according to the present invention, and the blue line graph shows the growth curve of the Hybridoma cells cultured in the GIBCO Hybridoma-SFM medium. The maximum growth density of AE-1 cells in the serum-free medium of the present invention was significantly higher than that of the control SFM medium.
(4) Monoclonal antibody expression level detection
Collecting culture supernatant from the cell culture to day 4 (Batch culture), purifying protein sample with protein A filler, and performing concentration analysis on the purified sample with microfluidic ultraviolet spectrophotometer. According to the calculation, the expression level of the monoclonal antibody in the culture supernatant was 101.5. Mu.g/ml.
Example 2 cell resuscitative test and comparison test with domestic commercial media.
(1) Preparation of the culture Medium
The following were added to the DMEM/F12 (v/v, 1:1) based medium:
Bovine serum albumin 15.0mg/L, transferrin 8mg/L, insulin 8mg/L, arginine 125mg/L, cystine 28mg/L, histidine 45mg/L, isoleucine 62mg/L, leucine 52mg/L, lysine 75mg/L, methionine 150mg/L, phenylalanine 30mg/L, threonine 50mg/L, tryptophan 10mg/L, tyrosine 40mg/L, valine 40mg/L, glycine 13mg/L, alanine 16mg/L, asparagine 18mg/L, aspartic acid 19mg/L, glutamic acid 25mg/L, proline 20mg/L, serine 12mg/L, glutamine 900mg/L, choline chloride 1mg/L, calcium pantothenate 1mg/L, folic acid 1mg/L, niacinamide 1mg/L, pyridoxal hydrochloride 1mg/L, riboflavin 0.1mg/L, thiamine 1mg/L, inositol 2mg/L, ferric ammonium citrate 8mg/L, sodium pyruvate 100mg/L, sodium chloride 85mg/L, tetramine oleic acid 85mg/L, oleic acid 130 μg/L, oleic acid and 130 μg/L. The medium was prepared according to the conventional method and then sterilized by filtration through a 0.22 μm microporous filter.
(2) Cell resuscitation test
The Hybridoma cell line Hybridoma-2 cells (the Hybridoma-2 cells were prepared in the laboratory, the mouse myeloma cells Sp2/0 and the immunized mouse B lymphocytes were prepared by electrofusion techniques, and the obtained Hybridoma cells were selected) were resuscitated using the above serum-free medium into a 125mL shake flask in a culture volume of 30mL, and then cultured in a shake flask at 100rpm and 37℃under 5% CO 2 humidity.
Cell growth was observed after resuscitating cells: on the day of resuscitation, the cell density was 0.42×10 6 cells/ml and the viability was 96.5%, as shown in fig. 3; after 24h of culture, the cell density is 0.74×10 6 cells/ml, and the activity rate is 97.3%; after 48h of culture, the cell density is 2.05×10 6 cells/ml, and the activity rate is 98.1%; after 72h of incubation, the cell density was 3.62×10 6 cells/mL and the viability was 96.6%. The result shows that the serum-free culture medium can be suitable for the recovery operation of hybridoma cells.
(3) Comparing and testing with similar serum-free culture medium products of different domestic brands
The Hybridoma-2 cells are subjected to expansion culture to prepare cell suspension, then the culture medium (LPM) and other two similar serum-free culture medium products of different brands in China are respectively used, the first comparison product is HybriSFM-P1B serum-free culture medium of the company of Om Pu Mai, the second comparison product is Hyber-B100 serum-free culture medium of the company of double-skill, the initial culture density is about 0.3 x10 6 cells/mL, the culture volume is 30mL, and then the culture is placed in a saturated culture box with the humidity of 37 ℃ and 5% CO 2 for suspension culture.
As shown in FIG. 4, the orange-yellow line is the growth curve of the hybridoma cells cultured by the serum-free culture medium, the red line is the growth curve of the hybridoma cells of the first domestic similar comparison product, and the green line is the growth curve of the hybridoma cells of the second domestic similar comparison product. The viable cell density and the cell viability of the hybrid oma-2 cells cultured in the serum-free medium for 96 hours are higher than those of the domestic similar comparison medium.
The culture medium has the characteristics of low protein content and basically definite chemical composition, not only can meet the requirement of hybridoma cell suspension culture, but also can effectively avoid the problem that the product purification is not facilitated due to the use of serum; the culture medium also has the characteristic of strong universality, can obviously reduce the cost of cell culture solution, and is suitable for the mass production and industrial application of hybridoma cells.
The invention provides a thought and a method of a low-protein serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production, and the method and the way for realizing the technical scheme are numerous, the above is only a preferred embodiment of the invention, and it should be pointed out that a plurality of improvements and modifications can be made by those skilled in the art without departing from the principle of the invention, and the improvements and the modifications are also considered as the protection scope of the invention. The components not explicitly described in this embodiment can be implemented by using the prior art.
Claims (9)
1. A serum-free medium suitable for hybridoma cell suspension culture and monoclonal antibody production, wherein the serum-free medium comprises a basal medium and an additive factor, wherein:
The basic culture medium is DMEM and F12, and the volume ratio is 1:1;
the additive factors comprise protein components, amino acids, microorganisms, lipids, trace elements, protective agents and buffer solutions;
The protein component is bovine serum albumin, transferrin and insulin.
2. Serum-free medium according to claim 1, characterized in that the protein components are used in amounts of: bovine serum albumin 10.0-20.0 mg/L, transferrin 2.5-15.5 mg/L, insulin 5.0-15.0 mg/L.
3. The serum-free medium of claim 1, wherein the amino acids are present in the following composition and amounts: arginine 20-60 mg/L, cystine 5-15 mg/L, histidine 5-20 mg/L, isoleucine 10-25 mg/L, leucine 10-25 mg/L, lysine 10-25 mg/L, methionine 10-20 mg/L, phenylalanine 10-25 mg/L, threonine 10-25 mg/L, tryptophan 2-20 mg/L, tyrosine 5-20 mg/L, valine 10-30 mg/L, glycine 2-10 mg/L, alanine 2-10 mg/L, asparagine 2-20 mg/L, aspartic acid 2-20 mg/L, glutamic acid 2-20 mg/L, proline 2-20 mg/L and serine 2-20 mg/L.
4. The serum-free medium of claim 1, wherein the vitamins are present in the following amounts and components: 0.5 to 2.0 mg/L of choline chloride, 0.5 to 2.0 mg/L of calcium pantothenate, 0.5 to 2.0 mg/L of folic acid, 0.5 to 2.0 mg/L of niacinamide, 0.5 to 2.0 mg/L of pyridoxal hydrochloride, 0.5 to 2.0 mg/L of riboflavin, 0.5 to 2.0 mg/L of thiamine and 0.5 to 2.0 mg/L of inositol.
5. The serum-free medium of claim 1, wherein the lipid component and amount are: 10-50 mug/L of arachidonic acid, 1000-3000 mug/L of cholesterol, 30-300 mug/L of linoleic acid, 30-300 mug/L of linolenic acid, 30-300 mug/L of oleic acid, 30-300 mug/L of palmitoleic acid, 30-300 mug/L of stearic acid and 1000-4000 mug/L of ethanolamine.
6. The serum-free medium according to claim 1, wherein the trace element is sodium selenite in an amount of 2-20 μg/L.
7. The serum-free medium of claim 1, wherein the buffer is sodium bicarbonate and Hepes, the amount of sodium bicarbonate is 1-3 g/L, and the amount of Hepes is 2-40 mg/L.
8. The serum-free medium according to claim 1, wherein the shear resistant protective agent is Pluronic F-68 in an amount of 500-1000 mg/L.
9. Use of the serum-free medium according to any one of claims 1-8 for hybridoma cell suspension culture and monoclonal antibody production.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310041867.0A CN118325843A (en) | 2023-01-12 | 2023-01-12 | Low-protein serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310041867.0A CN118325843A (en) | 2023-01-12 | 2023-01-12 | Low-protein serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118325843A true CN118325843A (en) | 2024-07-12 |
Family
ID=91780739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310041867.0A Pending CN118325843A (en) | 2023-01-12 | 2023-01-12 | Low-protein serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118325843A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118813538A (en) * | 2024-09-04 | 2024-10-22 | 上海雅酶生物医药科技有限公司 | A serum-free culture medium for SP2/0 cell culture and its preparation method and application |
-
2023
- 2023-01-12 CN CN202310041867.0A patent/CN118325843A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118813538A (en) * | 2024-09-04 | 2024-10-22 | 上海雅酶生物医药科技有限公司 | A serum-free culture medium for SP2/0 cell culture and its preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105018416B (en) | A kind of non-animal derived culture medium of serum-free and its preparation method of the culture BHK-21 cell that suspends | |
Evans et al. | Studies of nutrient media for tissue cells in vitro I. A protein-free chemically defined medium for cultivation of strain L cells | |
Peehl et al. | Clonal growth of human keratinocytes with small amounts of dialyzed serum | |
CN101418330B (en) | Non protein culture medium adapted to large-scale culture of NSO cell and production of antibody | |
US4816401A (en) | Serum free cell culture medium | |
CN109337861B (en) | CHO cell serum-free medium supporting high expression of product | |
JPH04501660A (en) | Cell culture media for enhanced cell growth, culture longevity and product expression | |
WO2020103439A1 (en) | Low-protein serum-free cell culture medium | |
CN106834229B (en) | Serum-free medium for in vitro expansion of human immune killer cells | |
KR20070058584A (en) | Culture of Human Embryonic Stem Cells | |
CN101760442A (en) | Serum-free medium for MDCK cell large-scale adherent culture and single-cell suspension culture | |
CN106635953B (en) | Serum-free and protein-free cell culture medium | |
CN100362098C (en) | Serum-free medium suitable for large-scale culture of various animal cells | |
CN118325843A (en) | Low-protein serum-free culture medium suitable for hybridoma cell suspension culture and monoclonal antibody production and application thereof | |
CN104328158B (en) | Specific chemical components culture medium suitable for the large-scale production of animal cell expression product | |
CN106399224B (en) | Serum-free and protein-free cell culture medium | |
CN109370985A (en) | Serum-free medium for large-scale culture of human umbilical cord mesenchymal stem cells | |
CN111944741A (en) | Suspension culture domestication method of MDCK cell line | |
CN106801030B (en) | Serum replacement composition suitable for in vitro culture of liver-like cells and use method thereof | |
CN1087778C (en) | Hybridizing tumour cell non-serum culture medium | |
CN108103003B (en) | Serum-free medium adapting to PK-15 full-suspension growth, preparation method thereof and full-suspension domestication method applied to PK-15 cells | |
CN105462911B (en) | Serum-free medium for cultivating virus and preparation method thereof | |
Mitsuhashi | Establishment and characterization of continuous cell lines from pupal ovaries of the cabbage armyworm, Mamestra brassicae (Lepidoptera, Noctuidae) | |
CN104726400B (en) | Non-animal derived component cultural method of the human pluripotent stem cells to germline | |
CN112210542A (en) | Serum-free medium for culturing DF-1 cells and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |